Diabetes and stroke: Part two - Treating diabetes and stress hyperglycemia in hospitalized stroke patients

Current Cardiology Reports

Volumn 8, Issue 1, 2006, Pages 29-32

  Burroughs, Valentine ^a   Weinberger, Jesse ^b  

^a NORTH GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTILIPEMIC AGENT; GLUCAGON; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; NITRIC OXIDE SYNTHASE;

CEREBROVASCULAR ACCIDENT; CRITICALLY ILL PATIENT; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG MONITORING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE UNIT; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL STATUS; OUTPATIENT CARE; PATIENT CARE; POSTPRANDIAL STATE; REVIEW; STRESS; TREATMENT OUTCOME;

BLOOD GLUCOSE; CEREBROVASCULAR ACCIDENT; DIABETES COMPLICATIONS; DIABETES MELLITUS; HOSPITALIZATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; INSULIN;

EID: 33645091912     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-006-0007-0     Document Type: Review

References (26)

1. Van den Berghe G, Wouters P, Weekers F, et al.: Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367.
2. Stagnaro-Green A, Barton MK, Linekin PL, et al.: Mortality in hospitalized patients with hypoglycemia and severe hyperglycemia. Mt Sinai J Med 1995, 62:422-426.
3. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000, 355:773-778.
4. Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA 2003, 290:2041-2047.
5. Furnary AP, Wu Y, Bookin SO: Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 2004, 10(Suppl 2):21-33.
6. Almbrand B, Johannesson M, Sjostrand B, et al.: Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus: results from the DIGAMI study. Eur Heart J 2000, 21:733-739.
7. Clement S, Braithwaite SS, Magee MF, et al.: Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004, 27:553-591.
8. Garber AJ, Moghissi ES, Bransome ED, et al.: American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract 2004, 10:77-82.
9. Dandona P, Aljada A, Bandyopadhyay A: The potential therapentic role of insulin in acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995, 26:57-65.
10. Le Roith D: Molecular mechanisms by which metabolic control may improve outcomes. Endocr Pract 2004, 10(Suppl 2):57-62.
11. Montori VM, Bistrian BR, McMahon MM: Hyperglycemia in acutely ill patients. JAMA 2002, 288:2167-2169.
12. Hirsch IB, Braithwaite SS, Verderese CA: Practical Management of Inpatient Hyperglycemia. Sanofi-Aventis Monograph 06039. Lakeville, CT: Hilliard Publishing; 2005:1-41.
13. Trence DL, Kelly JL, Hirsch IB: the rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for a change. J Clin Endocrinol Metab 2003, 88:2430-2437.
14. Braithwaite SS, Buie MM, Thompson CL, et al.: Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract 2004, 10(Suppl2):89-99.
15. American Diabetes Association: Standards of medical care in diabetes. Diabetes Care 2005, 28:S4-S36.
16. Schloerb PR: Glucose in parenteral nutrition: a survey of US medical centers. J Parenter Enteral Nutr 2004, 28:447-452.
17. Jeejeebhoy KN: Permissive underfeeding of the critically ill patient. Nutr Clin Pract 2004, 19:477-480.
18. Campbell KB, Braithwaite SS: Hospital management of hyperglycemia. Clin Diabetes 2004, 22:81-88.
19. Bode BW, Braithwaite SS, Steed RD, Davidson PC: Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract 2004, 10:71-80.
20. Braithwaite SS: Case Study. Five steps to freedom: dose titration for type 2 diabetes using basal-prandial-correction insulin therapy. Clin Diabetes 2005, 23:39-43.
21. Hirsch IB: Insulin analogues. N Engl J Med 2005, 352:174-183.
22. DAFNE Study Group: Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomized controlled trial. BMJ 2002, 325:746.
23. DeWitt DE, Hirsch IB: Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. JAMA 2003, 289:2254-2264.
24. Hawkings JB, Morales CM, Shipp JC: Insulin requirements in 242 patients with type II diabetes mellitus. Endocr Pract 1995, 1:385-389.
25. Warshaw HS, Bolderman KM: Advanced carbohydrate counting. In Practical Carbohydrate Counting: a How-to-Teach Guide for Health Professionals. Alexandria: American Diabetes Association; 2001:26-28.
26. Shorr RI, Ray WA, Daugherty IR, Griffin MR: Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997, 157:1681-1686.